National Comprehensive Cancer Network



About NCCN

Breast Cancer Panel - Disclosures as of 1/13/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Benjamin O. Anderson, MD

None

None

None

None

None

Sarah L. Blair, MD

None

None

None

None

None

Harold J. Burstein, MD, PhD

None

None

None

None

None

Amy Cyr, MD

None

None

None

None

None

Anthony D. Elias, MD

None

Genentech, Inc.

None

None

None

William B. Farrar, MD

None

None

None

None

None

Andres Forero, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Sharon Hermes Giordano, MD, MPH

None

None

None

None

None

Lori J. Goldstein, MD

None

Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Nanostring;
Syntax

None

None

William J. Gradishar, MD

None

Bayer HealthCare;
Eisai Inc.;
Genentech, Inc.;
Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Daniel F. Hayes, MD

Janssen Pharmaceuticals

Inbiomotion;
Oncimmune

None

None

None

Clifford A. Hudis, MD

Alliance;
I-SPY2

None

None

ASCO;
Breast Cancer Research Foundation

None

Steven Jay Isakoff, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

None

Rashmi Kumar, PhD

None

None

None

None

None

Britt-Marie E. Ljung, MD

National Cancer Institute;
National Cancer Institute

None

None

None

None

P. Kelly Marcom, MD

Abbott Laboratories;
Veridex, LLC

Novartis Pharmaceuticals Corporation;
Nanostring

None

None

None

Ingrid A. Mayer, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Beryl McCormick, MD

None

None

None

None

None

Robert S. Miller, MD

None

None

None

None

None

Mark Pegram, MD

None

None

None

None

None

Lori J. Pierce, MD

None

Genomic Health, Inc.

None

UpToDate

None

Elizabeth C. Reed, MD

Agendia BV;
Novartis Pharmaceuticals Corporation

UnitedHealthcare

None

None

None

Kilian E. Salerno, MD

None

None

None

None

None

Lee S. Schwartzberg, MD, FACP

None

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

None

Dorothy Shead, MS

None

None

None

None

None

Mary Lou Smith, JD, MBA

None

None

None

Gateway for Cancer Research Foundation;
National Accreditation Program for Breast Centers

None

Hatem Soliman, MD

None

Agendia BV;
Celgene Corporation;
NanoString;
Veridex, LLC

None

None

None

George Somlo, MD

None

Celgene Corporation;
Genentech, Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Abraxane;
Abraxane;
Abraxane;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

John H. Ward, MD

None

None

None

None

None

Richard Zellars, MD

None

None

None

None

None